In this work, we demonstrated that blocking ANGPTL3 by VHH-Fc fusion protein could relieve hepatic lipid accumulation and liver injury in HF/HCCD-induced NAFLD mice. The gene discussed is ANGPTL3; the disease is metabolic dysfunction-associated steatotic liver disease.